HomeIMUX • NASDAQ
add
Immunic Inc
Previous close
$1.25
Day range
$1.18 - $1.26
Year range
$0.95 - $3.11
Market cap
112.15M USD
Avg Volume
224.36K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 23.88M | -12.37% |
Net income | -29.58M | -17.06% |
Net profit margin | — | — |
Earnings per share | -0.30 | 48.28% |
EBITDA | -23.86M | 12.36% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 97.31M | 0.21% |
Total assets | 104.16M | -4.33% |
Total liabilities | 20.58M | 16.57% |
Total equity | 83.58M | — |
Shares outstanding | 90.08M | — |
Price to book | 1.34 | — |
Return on assets | -75.36% | — |
Return on capital | -103.86% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -29.58M | -17.06% |
Cash from operations | -23.97M | -22.84% |
Cash from investing | -31.00K | -100.58% |
Cash from financing | 74.46M | 145,907.84% |
Net change in cash | 50.64M | 462.11% |
Free cash flow | -16.21M | -35.55% |
About
CEO
Founded
May 2003
Website
Employees
80